Biologics: a plain guide
What they are, when they're genuinely the right choice, the real risks, what they cost, and whether you can ever stop — explained plainly.


Treatment decisions in rheumatology are best made together with your treating rheumatologist, who knows your full history. These guides are here to help you understand the choices in plain language, so you can ask better questions and feel more settled about the plan you make with your doctor.
First, the plain-language version
Your immune system is attacking your own joints or tissues. Conventional medicines like methotrexate calm the immune system broadly. Biologics are different — they are precisely engineered proteins (made from living cells, hence the name) that block one specific chemical messenger driving the inflammation. Think of the difference between lowering the volume on the whole orchestra and silencing one instrument that's out of tune.
Because they're so targeted, they often work when other medicines haven't — and they can bring disease that seemed unstoppable under control. They are given by injection under the skin (usually at home) or by infusion (a drip in hospital), depending on the drug. A newer group, JAK inhibitors, are tablets that work in a similar targeted way and are often discussed alongside biologics.
The main types, without the jargon
| Group | What it blocks | Used mainly for | How it's given |
|---|---|---|---|
| Anti-TNF | TNF — a key inflammation messenger | Rheumatoid arthritis, spondyloarthritis, psoriatic arthritis | Injection under the skin every 1–4 weeks (or infusion) |
| Anti-IL-6 (e.g. tocilizumab) | Interleukin-6 | Rheumatoid arthritis, some vasculitis | Injection or infusion |
| Anti-IL-17 (e.g. secukinumab) | Interleukin-17 | Spondyloarthritis, psoriatic arthritis | Injection under the skin |
| B-cell therapy (rituximab) | B cells that make harmful antibodies | Rheumatoid arthritis, vasculitis, some lupus | Infusion, typically every 6 months |
| Abatacept | T-cell activation | Rheumatoid arthritis | Injection or infusion |
| JAK inhibitors (tablets) | Signalling inside immune cells | Rheumatoid, psoriatic, spondyloarthritis | Daily tablet |
Which one is right depends on your condition, other health issues, cost, and practicalities — there is no single "best" biologic.
When a biologic is genuinely the right call — and when it isn't
A biologic is not a last resort for end-stage disease. It is the right step when:
- Conventional medicines (methotrexate and others) have had a fair trial at a proper dose — usually 3–6 months — and the disease is still active
- The disease is aggressive or already damaging joints, where waiting risks permanent harm
- Conventional medicines can't be used because of side effects or other health problems
- Certain conditions (like ankylosing spondylitis) where conventional DMARDs simply don't work well for the spine
Sometimes methotrexate hasn't yet had a full trial — the dose, the duration, or absorption (tablets vs injection) can all matter. That's worth confirming before moving on, and it's something your rheumatologist will usually have considered.
What to expect if you start
- Screening first: TB test (IGRA or Mantoux) and chest X-ray — essential in India, where latent TB is common — plus hepatitis B and C, and a baseline blood check. Some vaccines are best given before you start (vaccine guide).
- Speed: many people notice improvement within 2–6 weeks; the full effect takes about 3 months. If nothing has changed by then, the drug is reassessed or switched — you are not stuck.
- Combination: biologics for rheumatoid arthritis usually work better with methotrexate, which also stops the body forming antibodies against the biologic. Stopping methotrexate when you start a biologic is a common mistake.
- Monitoring: periodic blood tests; a check-in every few months; a yearly vaccine review.
- Practicalities: injections are pre-filled and simple — most people self-inject after one demonstration. They need to be kept in the fridge (not the freezer); carry them in a cool bag when travelling.
Safety — the honest version
Biologics are powerful, so it's right to ask hard questions. Here is what the evidence actually shows:
- Infections are the main real risk. Because the immune system is dampened, ordinary infections can be a little more frequent and slower to clear. Serious infections are uncommon but real — which is why screening, vaccination, and a simple rule matter: if you have a fever or feel unwell, skip that dose and get seen.
- Tuberculosis deserves its own line in India. Biologics — especially anti-TNF — can reactivate hidden TB. Screening before starting, and treating latent TB if found, brings this risk down dramatically. This is not a reason to avoid biologics; it is the reason we screen.
- Cancer: the fear is understandable, but large registries following hundreds of thousands of patients have not shown biologics cause an overall increase in cancer. There may be a small increase in non-melanoma skin cancers with some drugs, so sun protection and skin checks are sensible. Importantly, uncontrolled rheumatoid arthritis itself raises lymphoma risk — controlling the disease may reduce it.
- Hepatitis B can reactivate — checked before starting, and manageable if known.
- Injection-site reactions (redness, itch) are common and harmless. Infusion reactions are watched for during the drip.
- JAK inhibitors specifically: regulators advise caution about blood clots, heart events and shingles, particularly in people over 65, smokers, or those with existing heart risk. For many patients they remain an excellent option; the decision is individual — and the shingles vaccine is worth planning.
- Untreated disease has its own risks: permanent joint damage, disability, heart disease, and a shortened life. The comparison is never "biologic vs nothing" — it's "biologic vs ongoing inflammation."
Cost, and why it's changed
This is the concern people are most embarrassed to raise, and the one most worth raising. Ten years ago biologics were out of reach for most Indian families. That is no longer true:
- Biosimilars — Indian-made versions of adalimumab, etanercept, infliximab, rituximab and tocilizumab — are approved, closely monitored, and cost a fraction of the originals. They are not "fake" or "weaker"; they are held to strict equivalence standards.
- JAK inhibitors like tofacitinib are available as low-cost generics in India, which is why they're now among the most-prescribed targeted drugs here.
- Government hospital treatment can substantially reduce or remove cost. Some patients qualify for state or central health schemes that cover these drugs — ask; don't assume.
- The cheapest option is not always the right one, and the costliest is not always better. The right choice fits your disease and your circumstances — discuss both openly with your rheumatologist.
Can you ever stop?
Yes — sometimes. Biologics are not a life sentence. If the disease stays in remission for a sustained period (usually 6–12 months or more), we can carefully reduce the dose or space out injections, and in some people stop, while watching closely. Some relapse and restart; some stay well. What doesn't work is stopping suddenly because you feel fine — remission is because of the drug, and stopping without a plan usually brings the disease back harder. Tapering is a decision we make together, never alone.
Pregnancy, surgery, and everyday life
- Pregnancy: several biologics (particularly some anti-TNF drugs) can be continued safely during pregnancy with planning; others are stopped. JAK inhibitors are avoided. Methotrexate and leflunomide must be stopped well before conception. If you're planning a family, tell me early — good control before conception gives the best pregnancy outcomes.
- Surgery: biologics are usually paused around an operation (typically skipping the dose before and resuming after wound healing) to reduce infection risk. Tell your surgeon you're on one.
- Missed dose: take it when you remember unless the next is close — then just continue the schedule. Don't double up.
- Alcohol, food, work, exercise: no specific restrictions from the biologic itself. Live normally.
- Illness: fever, a chest infection, or a wound that's getting worse — hold the dose and get checked. This is the single most important habit.
Been advised a biologic and want it explained properly?
Bring your reports. I'll explain what it means for you and what the options are. Consultations are walk-in, no appointment.
Clinic timings & location